Financing ·
Protagenic Therapeutics issues $250K promissory note to Patness LLC due in 180 days or upon equity raise
PTIXProtagenic Therapeutics, Inc.\new
On November 4, 2026, Protagenic Therapeutics issued a $250,000 promissory note to Patness LLC bearing simple interest at 1.0% per annum. The principal and accrued interest are due on the earlier of (i) the closing of an equity capital raise generating gross proceeds of at least $1,000,000 or (ii) 180 days from issuance. Interest is forgiven if paid in full within 365 days. This transaction represents a direct financial obligation for the biotechnology company focused on developing therapies.